VEGFA and Abnormal retinal morphology: Nevertheless, the safety of the intravitreal agent ziv-aflibercept has been proven in a retrospective multicenter study of 5916 eyes with various retinal diseases, and this agent has side effects similar to those of other intravitreal VEGF blockade agents [19].